Hemodiafiltration Versus Hemodialysis in Older People
HemoDiafiltration Versus HemoDialysis in OLDER People: a Randomized, Multicenter, Crossover, Pragmatic Clinical Trial
AUB Santé
62 participants
Feb 19, 2026
INTERVENTIONAL
Conditions
Summary
This study will compare the impact of two hemodialysis techniques on fatigue and post-dialysis recovery time in patients aged 85 years and older. These two techniques are high-flux hemodialysis (HD) and hemodiafiltration (HDF). Patients will receive the treatment over two periods: if period 1 is HD then period 2 will be HDF. Every patient will be his/her own control, this is why it is called cross-over. Each period will last three months. Between the two periods, patients will receive a traditional low-flux hemodialysis. These two techniques are widely used worldwide and their side-effects are well-known and do not put the patients at risk. HDF has been shown to improve survival in patients with a mean age of 58 years. But a previous study from the investigators' group showed that HDF causes a prolonged recovery time in older patients. This randomized trial aims to elucidate this question.
Eligibility
Inclusion Criteria7
- Signed and dated informed consent
- Age \>84 years
- Diagnosed with kidney failure
- On maintenance hemodialysis \>3months
- Willing to have a dialysis session of 3.5 to 4-hour duration, three times a week
- Has a reliable vascular access
- Is covered by the health insurance
Exclusion Criteria5
- Patients with cognitive impairment (assessed with a mini-test if needed)
- Hospitalized at inclusion
- Have difficulties with French speaking
- Terminally ill with life expectancy\<3 months
- With active cancer
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
High-flux hemodialysis removes small and middle molecular solutes through the mechanism of diffusion.
Hemodiafiltration removes solutes using convection which allows for more epuration of middle molecular solutes.
Locations(4)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07278973